Drreddys Laboratories | RDY - Gross Profit On Sales


Drreddys Laboratories reported INR43.04B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 143.88M 19.7M Mar/2026
Aurora Cannabis CAD 29.79M 16.83M Mar/2026
Bayer EUR 6.33B 1.84B Jun/2026
Canopy Growth CAD 8.26M 13.2M Mar/2026
Cipla INR 44.1B 5B Jun/2026
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Drreddys Laboratories INR 43.04B 3.77B Mar/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Novartis USD 11.24B 1.18B Jun/2026
Pacira USD 133.91M 7.27M Jun/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 136.19M 10.11M Jun/2026
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
Supernus Pharmaceuticals USD 160.06M 30.7M Jun/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026